Floatz logo

(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE

Alcohol Use Disorder (AUD)

South West Sydney Local Health DistrictSmall moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Alcohol Use Disorder (AUD) cohort.

Asset / SponsorPhaseRating
Naltrexone
Boston Medical Center
Phase 4BB
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
Boston Medical Center
Phase 2B
Pemvidutide
Altimmune, Inc.
Phase 2CCC
TEONANACATL
Centre for Addiction and Mental Health
Phase 2CCC
Tirzepatide
South West Sydney Local Health District
Phase 2CCC

View all 19 →

Same molecule, other indications

(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE is also rated in:

major depressive disorderDormant
BBB
Indicative ·
74 / 100
View asset →
major depressive disorderDormant
BBB
Indicative ·
74 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →